ARPE-19 and h1RPE7 cells (0.5–2.0×10
4 cells/100 µL in 96-well plate) were incubated with the addition of AGEs and/or HQ for 24 h. After the treatment, the viable cell numbers were determined by a
Cell Counting kit-8 (Dojindo Laboratories, Mashikimachi, Japan) according to the manufacture's instructions as described [20] (
link), [21] (
link), [22] (
link). Briefly, WST-8 (2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazoliummonosodium salt) solution was added to cells in 96-well plates, and the cells were incubated at 37 °C for 1–2 h. The optical density of each well was read at 450 nm (reference wave length at 650 nm) using a Sunrise
TM microplate reader (Tecan, Männedorf, Switzerland).
To investigate effects of VEGF-A on cell growth in RPE cells, ARPE-19 cells (2.0×10
4 cells/100 µL in 96-well plate) were incubated with AGEs, HQ, in the presence of VEGF-A/VEGF-A receptor inhibitors (10 µg/mL sulochrin (Sigma-Aldrich, St. Louis, MO) [23] (
link), 3 nM Ki8751 (Calbiochem
®) [24] (
link) or 50 nM CBO-P11 (Calbiochem
®) [25] (
link)), or siRNA against
VEGF or receptor for AGE (
RAGE) for 24 h. After the treatment, the viable cell numbers were determined by a
Cell Counting kit-8 (Dojindo) according to the manufacture's instructions.
Tsujinaka H., Itaya-Hironaka A., Yamauchi A., Sakuramoto-Tsuchida S., Ota H., Takeda M., Fujimura T., Takasawa S, & Ogata N. (2015). Human retinal pigment epithelial cell proliferation by the combined stimulation of hydroquinone and advanced glycation end-products via up-regulation of VEGF gene. Biochemistry and Biophysics Reports, 2, 123-131.